Exogenous surfactant therapy in a patient with adult respiratory distress syndrome after near drowning

被引:13
作者
Staudinger, T [1 ]
Bankier, A [1 ]
Strohmaier, W [1 ]
Weiss, K [1 ]
Locker, GJ [1 ]
Knapp, S [1 ]
Roggla, M [1 ]
Laczika, K [1 ]
Frass, M [1 ]
机构
[1] UNIV VIENNA,DEPT INTERNAL MED 1,A-1090 VIENNA,AUSTRIA
关键词
near-drowning; adult respiratory distress syndrome; surfactant;
D O I
10.1016/S0300-9572(97)00055-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A 24-year-old woman developed adult respiratory distress syndrome (ARDS) after near-drowning due to attempted suicide. Conventional mechanical ventilation together with prone positioning and inhaled nitric oxide could not provide sufficient oxygenation. Surface tension data (gamma min = 27 dyn/cm, stability index = 0.341) from a lavage sample supported the hypothesis that the surfactant function of this patient was drastically reduced due to a washout effect by aspiration of fresh water. Porcine surfactant (Curosurf(R), 50 mg/kg for each lung) was instilled via fibreoptic bronchoscope. The partial arterial carbon dioxide pressure (paCO(2)) and fraction of inspired oxygen (FiO(2)) ratio as well as shunt fraction (Qs/Qt) improved impressively. When respiratory situation deteriorated again, surfactant application was repeated. Altogether, six bolus instillations of surfactant (total dose 300 mg/kg = 18 000 mg) were administered until the respiratory situation had stabilized and oxygenation could be maintained by conventional mechanical ventilation. The radiological findings did not show substantial amelioration. The patient developed septic shock and died 12 days after admission. Surfactant application apparently led to a significant improvement of the respiratory function. However, the outcome could not be influenced positively. The high cost of surfactant therapy prevents the more widespread early administration in patients at risk. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:179 / 182
页数:4
相关论文
共 17 条
[1]   Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome [J].
Anzueto, A ;
Baughman, RP ;
Guntupalli, KK ;
Weg, JG ;
Wiedemann, HP ;
Raventos, AA ;
Lemaire, F ;
Long, W ;
Zaccardelli, DS ;
Pattishall, EN .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (22) :1417-1421
[2]  
GOMMERS D, 1993, CLIN INTENSIVE CARE, V4, P284
[3]  
GREGORY TJ, 1994, AM J RESP CRIT CARE, V149, pA567
[4]   SURFACTANT REPLACEMENT THERAPY IN LATE-STAGE ADULT-RESPIRATORY-DISTRESS-SYNDROME [J].
HASLAM, PL ;
HUGHES, DA ;
MACNAUGHTON, PD ;
BAKER, CS ;
EVANS, TW .
LANCET, 1994, 343 (8904) :1009-1011
[5]   SUCCESSFUL TREATMENT OF ARDS WITH 2 DOSES OF SYNTHETIC SURFACTANT [J].
HEIKINHEIMO, M ;
HYNYNEN, M ;
RAUTIAINEN, P ;
ANDERSSON, S ;
HALLMAN, M ;
KUKKONEN, S .
CHEST, 1994, 105 (04) :1263-1264
[6]  
JOBE AH, 1993, NEW ENGL J MED, V328, P861
[7]   IN-VIVO EVALUATION OF THE INHIBITORY CAPACITY OF HUMAN PLASMA ON EXOGENOUS SURFACTANT FUNCTION [J].
LACHMANN, B ;
EIJKING, EP ;
SO, KL ;
GOMMERS, D .
INTENSIVE CARE MEDICINE, 1994, 20 (01) :6-11
[8]  
LACHMANN B, 1992, PULMONARY SURFACTANT, P635
[9]   SURFACTANT AND THE ADULT RESPIRATORY-DISTRESS SYNDROME [J].
LEWIS, JF ;
JOBE, AH .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (01) :218-233
[10]   LUNG-FUNCTION AND SURFACTANT DISTRIBUTION IN SALINE-LAVAGED SHEEP GIVEN INSTILLED VS NEBULIZED SURFACTANT [J].
LEWIS, JF ;
TABOR, B ;
IKEGAMI, M ;
JOBE, AH ;
JOSEPH, M ;
ABSOLOM, D .
JOURNAL OF APPLIED PHYSIOLOGY, 1993, 74 (03) :1256-1264